A.G.K. Reddy et al. / Tetrahedron 69 (2013) 10098e10107
10105
J¼12.2 Hz, CH]CHCO), 7.03 (dd, 1H, J¼8.3 and 2.4 Hz, AreH), 7.01
(d, 1H, J¼2.4 Hz, AreH), 6.22 (d, 1H, J¼12.2 Hz, CH]CHCO), 5.12 (s,
2H, PhCH2O), 5.00 (s, 2H, ArCH2O) ppm. 13C NMR (CDCl3, 100 MHz):
then with Pd(OAc)2 (6.9 mg, 10 mol %), PPh3 (16.3 mg, 20 mol %) for
Heck coupling at 80 ꢀC for 24 h and finally with DMF (3 mL) at
120 ꢀC for 12 h. Purification of the crude material by silica gel
column chromatography (petroleum ether/ethyl acetate, 85:15 to
75:25) furnished the lactenone 5ae (40.5 mg, 44%) as colorless
solid, recrystallized from dichloromethane/petroleum ether
(mp 160e161 ꢀC). [TLC control (petroleum ether/ethyl acetate
75:25), Rf (1e)¼0.45, Rf (5ae)¼0.38, UV detection]. IR (MIR-ATR,
4000e600 cmꢁ1): nmax¼2925, 1694, 1602, 1517, 1453, 1354, 1275,
d¼168.0 (s, O]CeO), 160.1 (s, AreC), 140.6 (d, CH]CHCO), 137.1 (s,
AreC), 136.0 (s, AreC), 131.7 (d, AreCH), 128.7 (d, 2C, AreCH),
128.5 (s, AreC), 128.3 (d, AreCH), 127.4 (d, 2C, AreCH), 120.2 (d,
CH]CHCO), 115.7 (d, AreCH), 115.1 (d, AreCH), 70.3 (t, PhCH2O),
68.7 (t, ArCH2O) ppm. HR-MS (APCIþ) m/z calculated for
[C17H15O3]þ¼[MþH]þ: 267.1016; found 267.1020.
1164, 1106, 1031, 987, 864, 733, 698 cmꢁ1
.
1H NMR (CDCl3,
4.11. 8-Methoxy-2-benzoxepin-3(1H)-one (5ac)
400 MHz):
d
¼7.42 (d, 2H, J¼7.8 Hz, AreH), 7.37 (dd, 2H, J¼7.8 and
7.3 Hz, AreH), 7.31 (t, 1H, J¼7.3 Hz, AreH), 7.04 (d, 1H, J¼12.2 Hz,
CH]CHCO), 6.91 (s, 1H, AreH), 6.89 (s, 1H, AreH), 6.22 (d, 1H,
J¼12.2 Hz, CH]CHCO), 5.16 (s, 2H, PhCH2O), 4.97 (s, 2H, ArCH2O),
GP-1 was carried out with alcohol 1c (100.0 mg, 0.46 mmol),
ethyl acrylate (230.3 mg, 2.30 mmol), Cs2CO3 (449.6 mg,
1.38 mmol), toluene (2 mL) for Michael addition at 50 ꢀC for 48 h,
then with Pd(OAc)2 (10.3 mg,10 mol %), PPh3 (24.1 mg, 20 mol %) for
Heck coupling at 80 ꢀC for 24 h and finally with DMF (3 mL) at
120 ꢀC for 12 h. Purification of the crude material by silica gel
column chromatography (petroleum ether/ethyl acetate, 90:10 to
80:20) furnished the lactenone 5ac (40.4 mg, 46%) as a pale brown
solid, recrystallized from dichloromethane/hexane (mp 96e98 ꢀC).
[TLC control (petroleum ether/ethyl acetate 80:20), Rf (1c)¼0.45, Rf
(5ac)¼0.40, UV detection]. IR (MIR-ATR, 4000e600 cmꢁ1):
nmax¼2926, 1699, 1605, 1503, 1453, 1284, 1251, 1160, 1034, 909, 805,
3.93 (s, 3H, AreOCH3) ppm. 13C NMR (CDCl3, 100 MHz):
d
¼168.0 (s,
O]CeO), 150.9 (s, AreC), 148.7 (s, AreC), 140.6 (d, CH]CHCO),
136.3 (s, AreC), 129.2 (s, AreC), 128.6 (d, 2C, AreCH), 128.4 (s,
AreC), 128.1 (d, AreCH), 127.2 (d, 2C, AreCH), 120.7 (d, CH]CHCO),
114.7 (d, AreCH), 111.7 (d, AreCH), 71.1 (t, PhCH2O), 68.3 (t,
ArCH2O), 56.2 (q, AreOCH3) ppm. HR-MS (APCIþ) m/z calculated for
[C18H17O4]þ¼[MþH]þ: 297.1121; found 297.1120.
4.14. [1,3]Dioxolo[4,5-h][2]benzoxepin-7(5H)-one (5af)
727 cmꢁ1
.
1H NMR (CDCl3, 400 MHz):
d
¼7.34 (d, 1H, J¼8.3 Hz,
GP-1 was carried out with alcohol 1f (100.0 mg, 0.43 mmol),
ethyl acrylate (215.2 mg, 2.15 mmol), Cs2CO3 (423.0 mg,1.30 mmol),
toluene (2 mL) for Michael addition at 50 ꢀC for 48 h, then
with Pd(OAc)2 (9.6 mg, 10 mol %), PPh3 (22.5 mg, 20 mol %) for
Heck coupling at 80 ꢀC for 24 h and finally with DMF (3 mL) at
120 ꢀC for 12 h. Purification of the crude material by silica gel
column chromatography (petroleum ether/ethyl acetate, 90:10
to 80:20) furnished the lactenone 5af (38.6 mg, 44%) as colorless
solid, recrystallized from dichloromethane/petroleum ether
(mp 149e150 ꢀC). [TLC control (petroleum ether/ethyl acetate
80:20), Rf (1f)¼0.45, Rf (5af)¼0.40, UV detection]. IR (MIR-ATR,
4000e600 cmꢁ1): nmax¼2921, 1698, 1617, 1504, 1490, 1387, 1267,
AreH), 7.14 (d, 1H, J¼12.2 Hz, CH]CHCO), 6.96 (dd, 1H, J¼8.3 and
2.4 Hz, AreH), 6.92 (d, 1H, J¼2.4 Hz, AreH), 6.21 (d, 1H, J¼12.2 Hz,
CH]CHCO), 5.01 (s, 2H, ArCH2O), 3.85 (s, 3H, AreOCH3) ppm. 13
C
NMR (CDCl3, 100 MHz):
d
¼168.1 (s, O]CeO), 161.0 (s, AreC), 140.7
(d, CH]CHCO), 137.0 (s, AreC), 131.7 (d, AreCH), 128.3 (s, AreC),
120.0 (d, CH]CHCO), 114.8 (d, AreCH), 114.2 (d, AreCH), 68.7 (t,
ArCH2O), 55.5 (q, AreOCH3) ppm. HR-MS (APCIþ) m/z calculated for
[C11H11O3]þ¼[MþH]þ: 191.0703; found 191.0704.
4.12. 8-(Benzyloxy)-7-methoxy-2-benzoxepin-3(1H)-one
(5ad)
1238, 1147, 1023, 928, 879 cmꢁ1. 1H NMR (CDCl3, 400 MHz):
d
¼7.06
GP-1 was carried out with alcohol 1d (100.0 mg, 0.31 mmol),
ethyl acrylate (155.2 mg, 1.55 mmol), Cs2CO3 (303.0 mg,
0.93 mmol), toluene (2 mL) for Michael addition at 50 ꢀC for 48 h,
then with Pd(OAc)2 (6.9 mg, 10 mol %), PPh3 (16.3 mg, 20 mol %) for
Heck coupling at 80 ꢀC for 24 h and finally with DMF (3 mL) at
120 ꢀC for 12 h. Purification of the crude material by silica gel
column chromatography (petroleum ether/ethyl acetate, 85:15 to
75:25) furnished the lactenone 5ad (38.6 mg, 42%) as white solid,
recrystallized from dichloromethane/hexane (mp 159e160 ꢀC).
[TLC control (petroleum ether/ethyl acetate 75:25), Rf (1d)¼0.45, Rf
(5ad)¼0.38, UV detection]. IR (MIR-ATR, 4000e600 cmꢁ1):
nmax¼2924, 1702, 1603, 1519, 1368, 1275, 1165, 1025, 740 cmꢁ1. 1H
(d,1H, J¼12.2 Hz, CH]CHCO), 6.86 (s, 1H, AreH), 6.83 (s, 1H, AreH),
6.24 (d, 1H, J¼12.2 Hz, CH]CHCO), 6.03 (s, 2H, OeCH2eO), 4.93 (s,
2H, ArCH2O) ppm. 13C NMR (CDCl3, 100 MHz):
d¼167.8 (s, O]CeO),
149.0 (s, AreC), 148.7 (s, AreC), 140.3 (d, CH]CHCO), 130.2 (s,
AreC), 130.0 (s, AreC), 121.0 (d, CH]CHCO), 109.3 (d, AreCH), 109.0
(d, AreCH), 101.9 (t, OeCH2eO), 68.2 (t, ArCH2O) ppm. HR-MS
(APCIþ) m/z calculated for [C11H9O4]þ¼[MþH]þ: 205.0495; found
205.0493.
4.15. 7,8-Dimethoxy-2-benzoxepin-3(1H)-one (5ag)
GP-1 was carried out with alcohol 1g (100.0 mg, 0.40 mmol),
ethyl acrylate (202.6 mg, 2.02 mmol), Cs2CO3 (395.6 mg,
1.21 mmol), toluene (2 mL) for Michael addition at 50 ꢀC for 48 h,
then with Pd(OAc)2 (9.1 mg, 10 mol %), PPh3 (21.0 mg, 20 mol %) for
Heck coupling at 80 ꢀC for 24 h and finally with DMF (3 mL) at
120 ꢀC for 12 h. Purification of the crude material by silica gel
column chromatography (petroleum ether/ethyl acetate, 85:15 to
70:30) furnished the lactenone 5ag (42.8 mg, 48%) as yellow semi-
solid. [TLC control (petroleum ether/ethyl acetate 75:25), Rf (1g)¼
0.45, Rf (5ag)¼0.30, UV detection]. IR (MIR-ATR, 4000e600 cmꢁ1):
nmax¼2924, 1693, 1603, 1519, 1463, 1356, 1274, 1247, 1164, 1107,
NMR (CDCl3, 400 MHz):
d
¼7.42 (d, 2H, J¼7.8 Hz, AreH), 7.38 (dd,
2H, J¼7.8 and 7.3 Hz, AreH), 7.32 (t, 1H, J¼7.3 Hz, AreH), 7.11 (d, 1H,
J¼12.2 Hz, CH]CHCO), 6.91 (s, 1H, AreH), 6.89 (s, 1H, AreH),
6.25 (d, 1H, J¼12.2 Hz, CH]CHCO), 5.20 (s, 2H, PhCH2O), 4.92 (s,
2H, ArCH2O), 3.91 (s, 3H, AreOCH3) ppm. 13C NMR (CDCl3,
100 MHz):
d
¼167.9 (s, O]CeO), 150.3 (s, AreC), 149.5 (s, AreC),
140.5 (d, CH]CHCO), 136.2 (s, AreC), 129.0 (s, AreC), 128.7 (d, 2C,
AreCH), 128.6 (s, AreC), 128.2 (d, AreCH), 127.2 (d, 2C, AreCH),
121.0 (d, CH]CHCO), 113.7 (d, AreCH), 112.7 (d, AreCH), 71.1 (t,
PhCH2O), 68.3 (t, ArCH2O), 56.2 (q, AreOCH3) ppm. HR-MS (APCIþ)
m/z calculated for [C18H17O4]þ¼[MþH]þ: 297.1121; found 297.1121.
1029, 988, 840, 731 cmꢁ1. 1H NMR (CDCl3, 400 MHz):
d¼7.12 (d, 1H,
J¼12.2 Hz, CH]CHCO), 6.90 (s, 1H, AreH), 6.87 (s, 1H, AreH),
6.26 (d, 1H, J¼12.2 Hz, CH]CHCO), 4.98 (s, 2H, ArCH2O), 3.93 (s,
3H, ArOCH3), 3.90 (s, 3H, ArOCH3) ppm. 13C NMR (CDCl3,
4.13. 7-(Benzyloxy)-8-methoxy-2-benzoxepin-3(1H)-one (5ae)
GP-1 was carried out with alcohol 1e (100.0 mg, 0.31 mmol),
ethyl acrylate (155.2 mg, 1.55 mmol), Cs2CO3 (303.0 mg,
0.93 mmol), toluene (2 mL) for Michael addition at 50 ꢀC for 48 h,
100 MHz):
d
¼168.0 (s, O]CeO), 150.3 (s, AreC), 149.7 (s,
AreC), 140.6 (d, CH]CHCO), 128.7 (s, AreC), 128.6 (s, AreC), 120.9
(d, CH]CHCO), 112.1 (d, AreCH), 111.3 (d, AreCH), 68.3 (t, ArCH2O),